CAR-T

Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Fierce Biotech
Novartis
Legend Biotech
CAR-T
T-Charge
solid tumors
Flag link:
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
Flag link:
Aleta aims for pivotal US trial with CAR T-cell engager
Aleta aims for pivotal US trial with CAR T-cell engager
Clinical Trials Arena
Aleta Biotherapeutics
CAR-T
ALETA-001
clinical trials
Flag link:
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Kite publishes Phase II data for Yescarta in treating B-cell lymphoma
Clinical Trials Arena
Gilead Sciences
Kite Pharma
Yescarta
clinical trials
CAR-T
relapsed or refractory large B-cell lymphoma
Flag link:
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Flag link:
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
BioSpace
Moderna Therapeutics
CARsgen
MRNA
cancer
cancer vaccine
vaccines
solid tumors
CAR-T
Flag link:
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
Flag link:
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
Fierce Biotech
Gilead Sciences
Arcellx
CAR-T
cell therapy
FDA
Flag link:
FDA puts 2seventy CAR-T trial on hold in wake of patient death
FDA puts 2seventy CAR-T trial on hold in wake of patient death
Fierce Biotech
2seventy bio
clinical trials
FDA
patient deaths
AML
CAR-T
Flag link:
Regenerative Medicine Challenges Hinder Their Development and Use: GAO
Regenerative Medicine Challenges Hinder Their Development and Use: GAO
BioSpace
regenerative medicine
CAR-T
stem cells
GAO
Flag link:
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
Flag link:
Pfizer pours $25M investment into Caribou's cell therapies
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Flag link:
Cartesian maps the path for an autoimmune disease cell therapy
Cartesian maps the path for an autoimmune disease cell therapy
EP Vantage
Cartesian Therapeutics
MRNA
CAR-T
autoimmune disease
Flag link:
FDA places clinical hold on Arcellx’s multiple myeloma therapy trial
FDA places clinical hold on Arcellx’s multiple myeloma therapy trial
Clinical Trials Arena
Arcellx
CAR-T
CART-ddBCMA
relapsed or refractory multiple myeloma
FDA
clinical trials
Flag link:
CAR-T beyond cancer? Novartis and others say yes
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
CAR-T
Novartis
Cabaletta Bio
Cartesian Therapeutics
Bristol Myers Squibb
Gracell
Yake Biotechnology
Flag link:
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
BioSpace
Tessa Therapeutics
CAR-T
Hodgkin's lymphoma
TT11X
Flag link:
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Fierce Biotech
2seventy bio
Bluebird Bio
CAR-T
patient death
clinical trials
AML
Flag link:
ASCO 2023: Precigen reports positive early data for CAR-T therapy
ASCO 2023: Precigen reports positive early data for CAR-T therapy
BioSpace
ASCO 2023
Precigen
CAR-T
PRGN-3005
ovarian cancer
Flag link:
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
Flag link:
China dominates CAR-T therapies
China dominates CAR-T therapies
Clinical Trials Arena
China
cancer
CAR-T
Flag link:

Pages